Uniquely positioned to obtain funding and move projects forward

FCTDI works frequently with academic researchers at universities and non-profit research organizations. FCTDI is eligible for small business funding from the Federal Government. Partnerships work well between academic researchers with novel innovative pharmacology and FCTDI. FCTDI has industry-trained professionals with experience in the pharmaceutical industry, working in early-stage drug discovery research including medicinal chemistry, pharmacology and ADME characterization.

A CULTURE OF SCIENTIFIC INNOVATION & OPPORTUNITY

At FCTDI, there is the opportunity to treat human disease. We are inspired and passionate about our role in helping people around the world by preparing new therapeutics and discovering new medicines to treat disease. FCTDI scientists value the freedom to explore new ways to achieve our mission.

FCTDI uses modern methods of medicinal chemistry, literature searching and pharmacology. FCTDI is deeply involved with the creation of new intellectual property, in assisting our partners in writing patent applications and the patent prosecution process. With the introduction of three new drug candidates into human clinical trials, FCTDI’s impact exceeds outcomes that seem possible for a company of our size.

At FCTDI, collaboration partners are valued and respected, and we share a mutual desire to succeed. Our core measure of success is to advance new compounds into human clinical trials. While the attrition rate for new medicines in human clinical trials is high, we expect that one or more of the candidates will be FDA approved and then commercialized for therapy.

WATCH VIDEO